Medium materiality6/10
Barclays raises GE HealthCare price target to $95 from $85
Why it may matterVerify against the original reporting
Bullish analyst view with material implied upside; treat as supportive, not definitive evidence.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lifted its GEHC target by about 12% to $95, roughly 25% above the cited $75.82 price. This is a meaningful bullish analyst update, though still an opinion rather than a company fundamental change.
- Barclays raised its GEHC target to $95 from $85.
- The new target is about 25% above the cited price.
Key facts
- 01
Target: $95
- 02
Posted price: $75.82
- 03
Analyst firm: Barclays
- 04
Analyst: Christopher Pasquale
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.